Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wants 80 a share soon
She wants to run hard we’ll see today
Nice group Twitter play yesterday $BPMX. Everyone unloaded already.
What covid play are you talking about
BPMX will move Fast. BPMX will move up Furious. $2-$3 on the COVID play. Anything under a buck is a free-bee.
* * $BPMX Video Chart 05-05-2020 * *
Link to Video - click here to watch the technical chart video
HOD $.569 lovely
This is why the Dow futures are so far in the red for Monday...!
https://www.breitbart.com/tech/2020/03/14/apple-closes-all-retail-stores-except-in-china/
There are videos of empty docks where millions of containers used to pass yearly. All because of the fear that the virus is on the outside or inside of the containers & ships.
Haven't been to a grocery store in a few days & at my nearby Walmart the choices are getting limited & a few rows are 1/3 to 1/2 empty. I could see it in the faces of the employees trying to restock the empty shelves...! The shit is about to 'hit the fan' in the next week or two.
Thank you Mr shorty for creating chaos worldwide...!!!
IBIO was allowed to run today as they issued puff press releases about four different times today. What a load of crap. We'll have our buying here soon...!
100 % no it has nothing to do with the virus. Its a PUMP AND DUMP make as much as one can on each pump. Don't get caught with it when it does the reverse split. sorry it was once a good company but now its well just look at it and one could see how bad it is.
Does this company have anything to do with Covid19?
I personally think the money managers & brokers were tired of clients pestering them as to why they haven't placed them in some bio stocks. That's why this sector was held down all day as the Dow again plummeted...! By the EOW we will all be much happier...MHO
Don't forget folks, since federal funds will be coming in the form of Grants to a number of CV virus companies, any current or future stock offering to raise funds maybe put on the back burner..? M H O
lol yesterday was a gift. I wonder which poor souls bought my shares up there I feel bad for them now. So now that I got a gift my wife will get a new Gift a Porshe. Be very careful here. Yesterday was a pump and dump. Sad to see it but that's all it was. If it goes lower under .40 or so ill buy back in for another pump. Have a great day
They no longer have this product.
The Company commercially launched its iodine breast health supplement, VI2OLET, in December 2014. In November 2018, the Company divested the rights to develop, manufacture, market and sell its molecular iodine technology, including VI2OLET. This divestiture resulted in a de minimis loss in the fourth quarter of fiscal year 2019, which is included in general and administrative expenses in the consolidated statements of operations and comprehensive loss. All tangible and intangible assets related to VI2OLET, including but not limited to existing customer and vendor arrangements, were included in this divestiture.
$BPMX BioPharmX Corporation Announces Violet™ Iodine is Now Available at The Vitamin Shoppe®
PR Newswire
MENLO PARK, Calif., April 20, 2015
MENLO PARK, Calif., April 20, 2015 /PRNewswire/ -- BioPharmX Corporation (OTCQB: BPMX), makers of Violet™ iodine, the new, once-daily, non-prescription iodine supplement for the relief of premenstrual breast discomfort*, today announced that new Violet iodine is now available at The Vitamin Shoppe®.
"The opportunity to work with one of the most well-known Vitamins, Minerals, and Supplements (VMS) specialty retailers allows us to further expand retail availability of our innovative product," said Anja Krammer, President of BioPharmX Corporation.
Violet iodine is available for sale at The Vitamin Shoppe stores nationwide. To learn more about Violet iodine, visit www.VioletDaily.com and follow us on Facebook and Twitter.
About BioPharmX Corporation
BioPharmX Corporation (OTCQB: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter ("OTC"), and supplement applications in the health and wellness markets, including women's health and dermatology. To learn more about BioPharmX, visit www.BioPharmX.com.
Forward-Looking Statements
Statements in this news release relating to the business of BioPharmX, which are not historical facts, are "forward-looking statements." These forward-looking statements may be identified by words such as "expect," "anticipate," "believe," or similar expressions that are intended to identify such forward-looking statements. All forward-looking statements are expressly qualified in their entirety by this cautionary statement and the risks and other factors detailed in the company's filings with the Securities and Exchange Commission (SEC). These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risk that the company's efforts to distribute Violet™ iodine through The Vitamin Shoppe's retail locations is unsuccessful. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this news release are made only as of the date hereof and the company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities law.
BioPharmX and Violet are pending trademarks of BioPharmX Inc. All other brand and product names are trademarks or registered trademarks of their respective holders.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biopharmx-corporation-announces-violet-iodine-is-now-available-at-the-vitamin-shoppe-300068088.html
SOURCE BioPharmX Corporation
* * $BPMX Video Chart 03-02-2020 * *
Link to Video - click here to watch the technical chart video
BioPharmX Corporatio (BPMX)
0.65 ? 0.2856 (78.38%)
Volume: 6,443,310 @03/02/20 4:31:51 PM EST
Bid Ask Day's Range
- - 0.394 - 0.7328
BPMX Detailed Quote
Wow what up with all that massive 1 share hit at .58?
.7328 Hod after hours could be fun....
YUP! tomorrow let's see dollar land. weeeeeeeeee
.71 7 minutes before market close over 90% today any news
Nice move today Brother
Whoooooola .65 +80% weeeeeeeeeeeee
We knew what he holding here
OMG....big move today isn’t it
thank you my friend, feeling better.
Not really but Phase 3 is coming
I grab a few more. I am not sure what is cooking but have to be good for a move like this.
this got anything to do wit coronavirus ?????
it is wow wowzer move, 'BioPharmX Corp. (BPMX)'
BioPharmX Corporatio (BPMX)
0.495 ? 0.1306 (35.84%)
Volume: 2,019,450 @03/02/20 3:15:12 PM EST
Bid Ask Day's Range
- - 0.394 - 0.5189
BPMX Detailed Quote
why hot
She is on fire today
NOT SURE WHAT EXACTLY COOKING HERE BUT I LIKE IT!
WOW! BPMX +38.56 OFF THE ROOF?
Followers
|
102
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3061
|
Created
|
02/04/13
|
Type
|
Free
|
Moderators |
In dermatology, for example, we are developing a unique way to deliver acne-fighting medicine topically. Today’s most effective acne medications must be ingested, risking undesirable side-effects. Topical treatments tend to be ineffective because their formulations do not deliver medication to the layer of skin where acne forms. Our developmental topical, called BPX-01, effectively delivers small amounts of antibiotic to the acne source, maximizing treatment effectiveness and reducing side-effects.
In women’s health, we are currently focused on improving breast health by treating fibrocystic breast condition, a medical problem that affects half the world’s women. The condition, which often produces breast tenderness and tissue density, can be treated with molecular iodine, which is effective but rarely found in a stable form. Our solution is Violet® iodine, a daily supplement that produces molecular iodine within the body – exactly where it can be most effective.
Both of these solutions demonstrate the power of BioPharmX’s unique combination of innovation and determination.
Currently in phase 2 of clinical development, BPX-01 may offer a breakthrough in acne treatment because it can deliver the antibiotic to the area of the skin where acne develops. The novel hydrophilic (non oil-based) formulation of minocycline may be more effective than other topical alternatives because they either use less effective antibiotics to penetrate the top layer of the skin or rely on higher concentrations of minocycline, which could lead to unpleasant side effects.
BPX-01 is the first and only stable hydrophilic topical gel with fully solubilized minocycline. Minocycline, an antibacterial and anti-inflammatory medicine, is the most commonly prescribed acne treatment because it has a lower resistance rate than other antibiotics. No stable form of hydrophilic topical minocycline is currently commercially available.
http://www.biopharmx.com/products/#dermatology
Morlock previously served as executive vice president and chief financial officer from 1994 to 2004 at Otis Spunkmeyer, a baked goods distribution company that has successfully pursued distribution of its products to small family-owned businesses all the way up to large worldwide organizations, including the U.S. Army. He served as controller there from 1992 to 1994. He also has experience garnered from these roles in various aspects of the retail industry, including going to market via various distribution channels, product merchandizing, customer relationship management, brand development, manufacturing, procurement, and inventory management.
"Stephen brings a unique blend of financial expertise and experience in the retail industry to BioPharmX," said Jim Pekarsky, chief executive officer and co-founder of BioPharmX Corporation. "His expertise and experience will prove valuable as we continue retail distribution expansion for Violet iodine."
Prior to his roles at Otis Spunkmeyer, Morlock held various management positions in accounting, financial planning and internal auditing at Westinghouse Electric Supply Company from 1977 to 1991. He holds a B.S. degree in Accounting from San Diego State University
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |